Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Exley

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Hospital Medicine (London, England : 1998)|June 25, 2005
Large granular lymphocyte leukaemia: a curable form of pulmonary arterial hypertension [corrected]L S G E Howard, S Chatterji, N W Morrell, et al.
Arthritis and Rheumatism|January 27, 1999
Localized bowel vasculitis: postoperative cyclophosphamide or not?K Raza, A R Exley, D M Carruthers, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 26, 2015
Recessive mutations in the cancer gene Ataxia Telangiectasia Mutated (ATM), at a locus previously associated with metformin response, cause dysglycaemia and insulin resistanceP J Connelly, N Smith, R Chadwick, et al.
British Journal of Rheumatology|March 6, 1998
Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI)A R Exley, P A Bacon, R A Luqmani, et al.
Rheumatology (Oxford, England)|July 26, 2000
Percutaneous image-guided biopsy of lung nodules in the assessment of disease activity in Wegener's granulomatosisD M Carruthers, S Connor, A J Howie, et al.
Clinical Radiology|January 10, 2012
Respiratory disease in common variable immunodeficiency and other primary immunodeficiency disordersF A Hampson, A Chandra, N J Screaton, et al.
Arthritis and Rheumatism|February 1, 1997
Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitidesA R Exley, P A Bacon, R A Luqmani, et al.
The European Respiratory Journal|June 30, 2006
Nontuberculous mycobacteria in bronchiectasis: Prevalence and patient characteristicsS J Fowler, J French, N J Screaton, et al.
Circulation|September 27, 2000
Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease?K Raza, J Thambyrajah, J N Townend, et al.
Lancet (London, England)|May 26, 1990
Monoclonal antibody to TNF in severe septic shockA R Exley, J Cohen, W Buurman, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Hospital Medicine (London, England : 1998)|June 25, 2005
Large granular lymphocyte leukaemia: a curable form of pulmonary arterial hypertension [corrected]L S G E Howard, S Chatterji, N W Morrell, et al.
Arthritis and Rheumatism|January 27, 1999
Localized bowel vasculitis: postoperative cyclophosphamide or not?K Raza, A R Exley, D M Carruthers, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 26, 2015
Recessive mutations in the cancer gene Ataxia Telangiectasia Mutated (ATM), at a locus previously associated with metformin response, cause dysglycaemia and insulin resistanceP J Connelly, N Smith, R Chadwick, et al.
British Journal of Rheumatology|March 6, 1998
Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI)A R Exley, P A Bacon, R A Luqmani, et al.
Rheumatology (Oxford, England)|July 26, 2000
Percutaneous image-guided biopsy of lung nodules in the assessment of disease activity in Wegener's granulomatosisD M Carruthers, S Connor, A J Howie, et al.
Clinical Radiology|January 10, 2012
Respiratory disease in common variable immunodeficiency and other primary immunodeficiency disordersF A Hampson, A Chandra, N J Screaton, et al.
Arthritis and Rheumatism|February 1, 1997
Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitidesA R Exley, P A Bacon, R A Luqmani, et al.
The European Respiratory Journal|June 30, 2006
Nontuberculous mycobacteria in bronchiectasis: Prevalence and patient characteristicsS J Fowler, J French, N J Screaton, et al.
Circulation|September 27, 2000
Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease?K Raza, J Thambyrajah, J N Townend, et al.
Lancet (London, England)|May 26, 1990
Monoclonal antibody to TNF in severe septic shockA R Exley, J Cohen, W Buurman, et al.
Pageof 3